Thymopentin
From Wikipedia, the free encyclopedia
 |
|
|
Thymopentin
|
|
| Systematic (IUPAC) name | |
| (3S)-3-[ [(2S)-6-amino-2-[ [(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[ [(2S)-1-[ [(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | L03 |
| PubChem | |
| Chemical data | |
| Formula | C30H49N9O9 |
| Mol. mass | 679.76496 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Thymopentin is an immunostimulant.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||
